Horizon Discovery (US) LLC
GPTKB entity
Statements (40)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Acquired_by_PerkinElmer
|
| gptkbp:awards |
Best Company to Work For
|
| gptkbp:CEO |
gptkb:Darrin_M._Disley
gptkb:Darrin_Disley |
| gptkbp:collaborations |
Academic institutions
|
| gptkbp:customerBase |
Research institutions
Academic researchers Biopharmaceutical companies |
| gptkbp:employees |
Over 200
Over 300 |
| gptkbp:focus |
Gene_editing_technologies
|
| gptkbp:founded |
2007
|
| gptkbp:headquarters |
gptkb:Cambridge,_UK
|
| https://www.w3.org/2000/01/rdf-schema#label |
Horizon Discovery (US) LLC
|
| gptkbp:industry |
Biotechnology
|
| gptkbp:investmentFocus |
Private equity
Venture capital funding Public offerings |
| gptkbp:location |
gptkb:United_States
|
| gptkbp:market |
Global biotechnology market
|
| gptkbp:mission |
Accelerate the discovery of new medicines
|
| gptkbp:parentCompany |
gptkb:Horizon_Discovery_Group_plc
|
| gptkbp:partnerships |
Various pharmaceutical companies
|
| gptkbp:products |
CRISPR technology
Transcription activator-like effector nucleases (TALENs) Zinc finger nucleases Gene_editing_tools |
| gptkbp:research |
Cancer research
Genetic disorders Drug discovery |
| gptkbp:services |
Cell line development
Genomic services Gene_editing |
| gptkbp:subsidiary |
gptkb:Horizon_Discovery_Group_plc
|
| gptkbp:technology |
Cell line engineering
Genome_editing Gene_editing |
| gptkbp:vision |
Transforming the way medicines are discovered and developed.
|
| gptkbp:website |
www.horizondiscovery.com
|